These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28451875)

  • 1. Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.
    Peckham AM; Fairman KA; Sclar DA
    Clin Drug Investig; 2017 Aug; 37(8):763-773. PubMed ID: 28451875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population.
    Peckham AM; Fairman KA; Sclar DA
    Drug Saf; 2018 Feb; 41(2):213-228. PubMed ID: 28956286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse and Misuse of Pregabalin and Gabapentin.
    Evoy KE; Morrison MD; Saklad SR
    Drugs; 2017 Mar; 77(4):403-426. PubMed ID: 28144823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin misuse, abuse and diversion: a systematic review.
    Smith RV; Havens JR; Walsh SL
    Addiction; 2016 Jul; 111(7):1160-74. PubMed ID: 27265421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population.
    Peckham AM; Evoy KE; Covvey JR; Ochs L; Fairman KA; Sclar DA
    Pharmacotherapy; 2018 Apr; 38(4):436-443. PubMed ID: 29484686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
    Chiappini S; Schifano F
    CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.
    Gomes T; Juurlink DN; Antoniou T; Mamdani MM; Paterson JM; van den Brink W
    PLoS Med; 2017 Oct; 14(10):e1002396. PubMed ID: 28972983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How addictive are gabapentin and pregabalin? A systematic review.
    Bonnet U; Scherbaum N
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1185-1215. PubMed ID: 28988943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
    Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
    Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of power-law analysis to predict abuse or diversion of prescribed medications: proof-of-concept mathematical exploration.
    Fairman KA; Peckham AM; Rucker ML; Rucker JH; Sclar DA
    BMC Res Notes; 2018 Jul; 11(1):523. PubMed ID: 30064519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world treatment of post-herpetic neuralgia with gabapentin or pregabalin.
    Johnson P; Becker L; Halpern R; Sweeney M
    Clin Drug Investig; 2013 Jan; 33(1):35-44. PubMed ID: 23179473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings.
    Buttram ME; Kurtz SP; Dart RC; Margolin ZR
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1083-1086. PubMed ID: 28493425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misuse and abuse of pregabalin and gabapentin: cause for concern?
    Schifano F
    CNS Drugs; 2014 Jun; 28(6):491-6. PubMed ID: 24760436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk to heroin users of polydrug use of pregabalin or gabapentin.
    Lyndon A; Audrey S; Wells C; Burnell ES; Ingle S; Hill R; Hickman M; Henderson G
    Addiction; 2017 Sep; 112(9):1580-1589. PubMed ID: 28493329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?
    Peckham AM; Fairman KA; Sclar DA
    Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse of Gabapentin is Associated with Opioid Addiction.
    Bastiaens L; Galus J; Mazur C
    Psychiatr Q; 2016 Dec; 87(4):763-767. PubMed ID: 26887855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).
    Evoy KE; Covvey JR; Peckham AM; Ochs L; Hultgren KE
    Res Social Adm Pharm; 2019 Aug; 15(8):953-958. PubMed ID: 31303196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy.
    Udall M; Harnett J; Mardekian J
    J Med Econ; 2012; 15(2):361-70. PubMed ID: 22181052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.